Eculizumab treatment in patients with COVID-19: Preliminary results from real life ASL Napoli 2 Nord experience

F. Diurno, F. G. Numis, G. Porta, F. Cirillo, S. Maddaluno, A. Ragozzino, P. D.E. Negri, C. D.I. Gennaro, A. Pagano, E. Allegorico, L. Bressy, G. Bosso, A. Ferrara, C. Serra, A. Montisci, M. D'Amico, S. Schiano Lo Morello, G. D.I. Costanzo, A. G. Tucci, P. MarchettiU. D.I. Vincenzo, I. Sorrentino, A. Casciotta, M. Fusco, C. Buonerba, M. Berretta, M. Ceccarelli, G. Nunnari, Y. Diessa, S. Cicala, G. Facchini

Research output: Contribution to journalReview articlepeer-review

Fingerprint Dive into the research topics of 'Eculizumab treatment in patients with COVID-19: Preliminary results from real life ASL Napoli 2 Nord experience'. Together they form a unique fingerprint.

Medicine & Life Sciences